OnKure Therapeutics, Inc.
OKUR
$2.53
-$0.01-0.39%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/28/2025
-
Ticker Report
4/16/2025
-
ETF Channel
4/14/2025
-
Ticker Report
4/3/2025
-
MarketBeat
3/29/2025
-
Simply Wall St
3/29/2025
-
MarketBeat
3/21/2025
-
MarketBeat
3/20/2025
-
Ticker Report
3/20/2025
-
MarketBeat
3/19/2025
-
MarketBeat
3/18/2025
-
The Fly
3/12/2025
-
TipRanks Financial Blog
3/12/2025
-
TipRanks Financial Blog
3/11/2025
-
TipRanks Financial Blog
3/11/2025
-
The Fly
3/11/2025
-
TipRanks Financial Blog
3/11/2025
-
The Fly
3/10/2025
-
Globe Newswire
3/4/2025
-
GuruFocus
3/4/2025
-
Globe Newswire
2/14/2025
-
GuruFocus
2/8/2025
-
GuruFocus
2/5/2025
-
TipRanks Financial Blog
1/31/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, March 10, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
End of July (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
720 307 2892
Address
6707 Winchester Circle
Boulder, CO 80301
Boulder, CO 80301
Country
Year Founded
--
Business Description
Sector
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its...
more